Consequences of the COVID-19 pandemic for patients with metabolic diseases-Reference-Cited by-同舟云学术

Consequences of the COVID-19 pandemic for patients with metabolic diseases

Published:2021-02-25 Issue:3 Volume:3 Page:289-292
ISSN:2522-5812
Container-title:Nature Metabolism
language:en
Short-container-title:Nat Metab

Author:

Bornstein Stefan R.^ORCID,Rubino Francesco,Ludwig Barbara,Rietzsch Hannes,Schwarz Peter E. H.,Rodionov Roman N.,Khunti Kamlesh,Hopkins David,Birkenfeld Andreas L.,Boehm Bernhard^ORCID,Amiel Stephanie,Holt Richard I. G.,Skyler Jay S.^ORCID,DeVries J. Hans,Renard Eric,Eckel Robert H.,Zimmet Paul^ORCID,Alberti K. G.,Geloneze Bruno^ORCID,Chan Juliana C.,Mbanya Jean Claude^ORCID,Onyegbutulem Henry C.,Ramachandran Ambady,Basit Abdul,Hassanein Mohamed,Spinas Giatgen A.,Beuschlein Felix^ORCID,Mingrone Geltrude^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Physiology (medical),Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://www.nature.com/articles/s42255-021-00358-y.pdf

Reference20 articles.

1. WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group. J. Am. Med. Assoc. 324, 1330–1341 (2020).

2. Rahman, S. A., Karmakar, A., Almustafa, M. M. & Kumar, N. J. Clin. Anesth. 46, 33–34 (2018).

3. Yu, B., Li, C., Sun, Y. & Wang, D. W. Cell Metab. 33, 65–77.e62 (2021).

4. Soldo, J. et al. Diabetes Care 43, e134–e136 (2020).

5. Londono, P., Komura, A., Hara, N. & Zipris, D. Clin. Immunol. 135, 401–411 (2010).

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Silent Syndrome of Long COVID and Gaps in Scientific Knowledge: A Narrative Review;Viruses;2024-08-05

2. Multifaceted nature of young-onset diabetes - can genomic medicine improve the precision of diagnosis and management?;Journal of Translational Genetics and Genomics;2024-01-19

3. Belief, knowledge, attitude and practices towards COVID-19 amongst residents of Abuja, Nigeria: implications for pandemic preparedness;The Pan African Medical Journal;2024

4. Microbiota-Based Therapeutics for COVID-19 and Sequelae;Human Microbiome;2024

5. Cross-Talk of NADPH Oxidases and Inflammation in Obesity;Antioxidants;2023-08-09